本文關(guān)鍵詞：microRNA與冠心病中醫(yī)證候研究，由筆耕文化傳播整理發(fā)布。

參考文獻(xiàn)/References:

［1］Qi Y X, Liu Y B, Rong W H. RNASeq and its applications: a new technology for transcriptomics［J］. Yi Chuan,2011,33(11):11911202.
［2］Kuersten S. A transposable approach to RNAseq from total RNA［J］. Nature Method,2012,9(6).
［3］Mcgettigan P A. Transcriptomics in the RNAseq era［J］. Curr Opin Chem Biol,2013,17(1):411.
［4］Marguerat S, Bahler J. RNAseq: from technology to biology［J］. Cell Mol Life Sci,2010,67(4):569579.
［5］Chen J X, Zhao H H, Wang W. Investigative strategy for research on biological basis of traditional Chinese medicine syndrome: feature selectionbased data mining methods［J］. Zhong Xi Yi Jie He Xue Bao,2010,8(8):747749.
［6］馬曉娟，殷惠軍，，陳可冀. 血瘀證患者差異基因表達(dá)譜研究［J］. 中西醫(yī)結(jié)合學(xué)報(bào),2008,(4):355360.
［7］嚴(yán)石林，沈宏春，王浩中，等. 3種疾病腎陽(yáng)虛證“同證異治”的信號(hào)通路調(diào)控研究［J］. 云南中醫(yī)學(xué)院學(xué)報(bào),2012,(1):59.
［8］黃進(jìn),胡華斌,謝陽(yáng)春，等.TUBB3,TS,ERCCI mRNA表達(dá)對(duì)晚期胃癌化療療效和預(yù)后的影響［J］.中南大學(xué)學(xué)報(bào)（醫(yī)學(xué)版）,2013,38(6):582589.
［9］Chen S L, Jiang J G. Application of gene differential expression technology in the mechanism studies of nature productderived drugs［J］. Expert Opin Biol Ther,2012,12(7):823839.
［10］Wang E T, Sandberg R, Luo S, et al. Alternative isoform regulation in human tissue transcriptomes［J］. Nature,2008,456(7221):470476.
［11］Choi M, Scholl U I, Ji W, et al. Genetic diagnosis by whole exome capture and massively parallel DNA sequencing［J］. Proc Natl Acad Sci U S A,2009,106(45):1909619101.
［12］劉喜德, 洪旭濤, 王云卿, 等. 溫化蠲痹方對(duì)膠原誘導(dǎo)性關(guān)節(jié)炎大鼠滑膜基因表達(dá)譜的影響［J］. 中國(guó)中西醫(yī)結(jié)合雜志， 2012(10):13981402.
［13］王東生，陳方平，賀石林，等. 大黃蟲(chóng)丸抗動(dòng)脈血栓形成的基因表達(dá)譜研究［J］. 中藥材， 2009(9): 14101413.
［14］仇鳳梅，曹巧巧，張如松. 中藥抗腫瘤有效成分的藥效基團(tuán)研究概況［J］. 現(xiàn)代腫瘤醫(yī)學(xué),2008，(4):666671.
［15］He Y H. General survey of traditional Chinese medicine and Western medicine researches on tumor metastasis［J］. Chin J Integr Med,2006,12(1):7580.
［16］Sun D Z, Jiao J P, Ju D W, et al. Tumor interstitial fluid and gastric cancer metastasis: an experimental study to verify the hypothesis of “tumorphlegm microenvironment”［J］. Chin J Integr Med,2012,18(5):350358.
［17］Chen Y J, Shieh C J, Tsai T H, et al. Inhibitory effect of norcantharidin, a derivative compound from blister beetles, on tumor invasion and metastasis in CT26 colorectal adenocarcinoma cells［J］. Anticancer Drugs,2005,16(3):293299.
［18］王秀峰, 蘇式兵. 中藥及其成分干預(yù)腫瘤轉(zhuǎn)移實(shí)驗(yàn)研究進(jìn)展［J］. 中國(guó)中藥雜志， 2008，(22):25832587.
［19］Spinelli V, Guillot P V, De Coppi P. Induced pluripotent stem (iPS) cells from human fetal stem cells (hFSCs)［J］. Organogenesis,2013,9(2):101110.
［20］Cloonan N, Forrest A R, Kolle G, et al. Stem cell transcriptome profiling via massivescale mRNA sequencing［J］. Nat Methods,2008,5(7):613619.
［21］范剛，周林，賴先榮，等. 基于代謝組學(xué)技術(shù)的中藥質(zhì)量控制研究思路探討［J］. 世界科學(xué)技術(shù)(中醫(yī)藥現(xiàn)代化),2010，(6):870875.
［22］殷惠軍,黃燁.病證結(jié)合動(dòng)物模型的研究進(jìn)展［J］.中國(guó)中西醫(yī)結(jié)合雜志，2013，33(1):810.
［23］Calin G A, Croce C M. MicroRNA signatures in human cancers［J］. Nat Rev Cancer,2006,6(11):857866.
［24］鄭思道，吳紅金，劉宇娜. microRNA在現(xiàn)代中醫(yī)藥研究中的作用和意義［J］. 中西醫(yī)結(jié)合心腦血管病雜志,2012，10(7):857860.
［25］Liu C G, Calin G A, Meloon B, et al. An oligonucleotide microchip for genomewide microRNA profiling in human and mouse tissues［J］. Proc Natl Acad Sci U S A,2004,101(26):97409744.
［26］王階, 虞桂. microRNA與冠心病中醫(yī)證候研究］［J］. 中國(guó)中西醫(yī)結(jié)合雜志, 2012(11):15621565.

[1]李白雪,張傳濤,張莉敏,等.慢性乙型病毒性肝炎中醫(yī)虛實(shí)辨證的分子生物學(xué)研究概述[J].環(huán)球中醫(yī)藥,2013,6(11):871.
　LI Bai xue,ZHANG Chuan tao,ZHANG Li min,et al.Overview of molecular biology research on differentiation of TCM syndroms of deficiency and excess on chronic hapatitis B[J].,2013,6(10):871.

  本文關(guān)鍵詞：microRNA與冠心病中醫(yī)證候研究，由筆耕文化傳播整理發(fā)布。